Atherosclerosis as a Possible Extrahepatic Manifestation of Chronic Hepatitis C Virus Infection
Author(s) -
Nobukazu Ishizaka,
Yuko Ishizaka,
Minoru Yamkado
Publication year - 2014
Publication title -
clinical medicine insights cardiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.634
H-Index - 21
ISSN - 1179-5468
DOI - 10.4137/cmc.s17069
Subject(s) - medicine , chronic hepatitis , comorbidity , hepatitis c virus , chronic infection , inflammation , population , artery , hepatitis c , immunology , virus , cardiology , immune system , environmental health
Chronic infection and associated inflammation may play a role in various unfavorable pathologic conditions, including atherosclerosis. Chronic hepatitis C virus (HCV) infection is thought to be associated with a higher prevalence of atherosclerotic vascular changes in the coronary artery, cerebrovascular artery, and carotid artery; however, little is known about the precise mechanisms by which HCV enhances atherogenic processes. Furthermore, some studies have found no association, or even an inverse association, between HCV infection and atherosclerotic vascular changes or cardiovascular events. Differences in data regarding the mode of association may be because of variations in sample size, target population, and study design. Nevertheless, physicians should be aware of cardiovascular disorders as a possible comorbidity - owing to their considerable consequences - among patients with chronic HCV infection.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom